Cat. No. 5811
Chemical Name: N1-(4-Chlorophenyl)-N2-(2,2,6,6-tet
Biological ActivityCD4 mimetic (IC50 values are in low micromolar range, dependent on cell type and HIV strain). Recognizes and induces structural changes in HIV-1 envelope protein gp120, analogous to CD4 binding. Inhibits HIV-1 cell entry in CXCR4 and CCR5 expressing cell lines, by blocking virus-cell and cell-cell fusion.
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Certificate of Analysis / Product Datasheet / Safety Datasheet
References are publications that support the products' biological activity.
Dogo-Isonagie et al (2012) Peptides from second extracellular loop of C-C chemokine receptor type 5 (CCR5) inhibit diverse strains of HIV-1. J.Biol.Chem. 287 15076. PMID: 22403408.
Kwon et al (2012) Unliganded HIV-1 gp120 core structures assume the CD4-bound conformation with regulation by quaternary interactions and variable loops. Proc.Natl.Acad.Sci.U.S.A. 109 5663. PMID: 22451932.
Zhao et al (2005) Identification of N-phenyl-N'-(2,2,6,6-tetramethyl-piperidin-4-yl)-oxalamides as a new class of HIV-1 entry inhibitors that prevent gp120 binding to CD4. Virology 339 213. PMID: 15996703.
If you know of a relevant reference for NBD 556 please let us know.
Citations are publications that use Tocris products.
Do you know of a great paper that uses NBD 556 from Tocris? If so please let us know.
View Related Products by Target
View Related Products by Product Action
Keywords: NBD 556, supplier, NBD556, CD4, mimetic, HIV, entry, blockers, gp120, envelope, proteins, Tocris Bioscience, Antiviral products
Find multiple products by catalog number
New Products in this Area
Antiviral; active against Zika, West Nile and dengue viruses25-Hydroxycholesterol
Antiviral; also α-crystallin (cryAB) chaperoneFilipin III
Polyene antibiotic; inhibits formation of pathological isoform of prion protein
Follow Tocris on LinkedIn
Visit our LinkedIn page for the latest Tocris news, events and updates.